Vertex Pharmaceuticals Inc
Company Description
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment...
Analysis Summary
CF franchise provides stable cash flow. Multiple late-stage programs in pain, kidney disease, and gene editing. Trading below historical P/E despite pipeline optionality.
Pro Analysis Locked
Upgrade to Pro to unlock detailed financial analysis, historical data, comparable companies, and AI-generated research reports.